UK-headquartered biodegradable plastics specialist Symphony Environmental Technologies has secured food-contact approval from the US Food and Drugs Administration (FDA) for its designed to protect (d2p) antimicrobial technology, to be used in polyethylene film to wrap bread.
The d2p technology is synergistic with d2w biodegradable technology and is designed to prevent the growth of bacteria on the surface of packaging film.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Approval for the technology was given under the Food Contact Notification procedure and has no time limit.
According to a clause of the Federal Food Drug and Cosmetic Act, the approval can be implemented only for Symphony products and prohibits any similar or identical substance to be manufactured or prepared by a company or person.
The FDA approval is expected to draw new commercial opportunities for the company in the western markets.
Symphony CEO Michael Laurier said: “After nearly ten years of investment and development we are pleased to have finally obtained food-contact approval for this d2p product in the USA.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“We are now in a position to move forward commercially and to bring this unique product to our global markets. We believe that this will make a significant contribution to revenues in the medium term.”
The company expects to sell the film to current customers while also attracting new ones.
The group has generated substantial revenues from the baking industry for its d2w technology.
Symphony has developed a range of additives, concentrates and master-batches marketed under its d2p trademark.
